Header Logo

Connection

Jocelyn Moyes to Female

This is a "connection" page, showing publications Jocelyn Moyes has written about Female.
Connection Strength

0,934
  1. Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
    View in: PubMed
    Score: 0,092
  2. Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 - 2018. BMC Infect Dis. 2024 Oct 09; 24(1):1128.
    View in: PubMed
    Score: 0,091
  3. Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017 10; 75(4):346-355.
    View in: PubMed
    Score: 0,055
  4. Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S217-26.
    View in: PubMed
    Score: 0,043
  5. Corynebacterium diphtheriae Infections, South Africa, 2015-2023. Emerg Infect Dis. 2025 Mar; 31(3):417-426.
    View in: PubMed
    Score: 0,023
  6. A Potential Platform for Future Vaccine Trials Identifies a High Incidence of Symptomatic and Asymptomatic Influenza Infection Among Children Aged 6 to 23 Months in South Africa. J Infect Dis. 2025 Feb 20; 231(2):e328-e336.
    View in: PubMed
    Score: 0,023
  7. The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya. BMC Public Health. 2024 09 04; 24(1):2410.
    View in: PubMed
    Score: 0,023
  8. Risk Factors for Severe COVID-19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020-2022. Influenza Other Respir Viruses. 2024 May; 18(5):e13300.
    View in: PubMed
    Score: 0,022
  9. Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study. J Infect. 2024 May; 88(5):106154.
    View in: PubMed
    Score: 0,022
  10. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. BMC Med. 2023 03 31; 21(1):120.
    View in: PubMed
    Score: 0,020
  11. Coronavirus Host Genomics Study: South Africa (COVIGen-SA). Glob Health Epidemiol Genom. 2022; 2022:7405349.
    View in: PubMed
    Score: 0,020
  12. Estimating the contribution of HIV-infected adults to household pneumococcal transmission in South Africa, 2016-2018: A hidden Markov modelling study. PLoS Comput Biol. 2021 12; 17(12):e1009680.
    View in: PubMed
    Score: 0,019
  13. Mortality in children aged <5 years with severe acute respiratory illness in a high HIV-prevalence urban and rural areas of South Africa, 2009-2013. PLoS One. 2021; 16(8):e0255941.
    View in: PubMed
    Score: 0,018
  14. Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017-18 (PHIRST): a population cohort study. Lancet Glob Health. 2021 06; 9(6):e863-e874.
    View in: PubMed
    Score: 0,018
  15. Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 10 21; 38(45):7007-7014.
    View in: PubMed
    Score: 0,017
  16. Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 06 02; 38(27):4288-4297.
    View in: PubMed
    Score: 0,017
  17. The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus-associated Severe Respiratory Illness in South African Infants, 2011-2016. Clin Infect Dis. 2019 11 27; 69(12):2208-2211.
    View in: PubMed
    Score: 0,016
  18. A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa. Vaccine. 2019 10 31; 37(46):6874-6884.
    View in: PubMed
    Score: 0,016
  19. Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014. J Pediatric Infect Dis Soc. 2019 Sep 25; 8(4):325-333.
    View in: PubMed
    Score: 0,016
  20. The performance of different case definitions for severe influenza surveillance among HIV-infected and HIV-uninfected children aged <5 years in South Africa, 2011-2015. PLoS One. 2019; 14(9):e0222294.
    View in: PubMed
    Score: 0,016
  21. Quantifying How Different Clinical Presentations, Levels of Severity, and Healthcare Attendance Shape the Burden of Influenza-associated Illness: A Modeling Study From South Africa. Clin Infect Dis. 2019 08 30; 69(6):1036-1048.
    View in: PubMed
    Score: 0,016
  22. The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013-2015. Influenza Other Respir Viruses. 2018 05; 12(3):360-373.
    View in: PubMed
    Score: 0,014
  23. The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia. Vaccine. 2018 02 08; 36(7):997-1007.
    View in: PubMed
    Score: 0,014
  24. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. Lancet Glob Health. 2017 10; 5(10):e984-e991.
    View in: PubMed
    Score: 0,014
  25. Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016. Emerg Infect Dis. 2017 07; 23(7):1124-1132.
    View in: PubMed
    Score: 0,014
  26. Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children. Clin Infect Dis. 2017 02 15; 64(4):443-450.
    View in: PubMed
    Score: 0,013
  27. Epidemiology of Acute Lower Respiratory Tract Infection in HIV-Exposed Uninfected Infants. Pediatrics. 2016 Apr; 137(4).
    View in: PubMed
    Score: 0,013
  28. Sapovirus prevalence in children less than five years of age hospitalised for diarrhoeal disease in South Africa, 2009-2013. J Clin Virol. 2016 May; 78:82-8.
    View in: PubMed
    Score: 0,013
  29. Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study. Influenza Other Respir Viruses. 2016 07; 10(4):324-32.
    View in: PubMed
    Score: 0,012
  30. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26; 15:450.
    View in: PubMed
    Score: 0,012
  31. Mortality Associated With Seasonal and Pandemic Influenza Among Pregnant and Nonpregnant Women of Childbearing Age in a High-HIV-Prevalence Setting-South Africa, 1999-2009. Clin Infect Dis. 2015 Oct 01; 61(7):1063-70.
    View in: PubMed
    Score: 0,012
  32. Deaths associated with respiratory syncytial and influenza viruses among persons =5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis. 2015 Apr; 21(4):600-8.
    View in: PubMed
    Score: 0,012
  33. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PLoS One. 2015; 10(3):e0118884.
    View in: PubMed
    Score: 0,012
  34. Epidemiology of severe acute respiratory illness (SARI) among adults and children aged =5 years in a high HIV-prevalence setting, 2009-2012. PLoS One. 2015; 10(2):e0117716.
    View in: PubMed
    Score: 0,012
  35. Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010-2011. BMC Infect Dis. 2015 Jan 27; 15:26.
    View in: PubMed
    Score: 0,012
  36. Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012. Pediatr Infect Dis J. 2015 Jan; 34(1):66-72.
    View in: PubMed
    Score: 0,012
  37. Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa. Influenza Other Respir Viruses. 2014 Sep; 8(5):567-73.
    View in: PubMed
    Score: 0,011
  38. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014 Nov 15; 210(10):1649-57.
    View in: PubMed
    Score: 0,011
  39. Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S227-37.
    View in: PubMed
    Score: 0,011
  40. Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S246-54.
    View in: PubMed
    Score: 0,011
  41. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013 Nov; 19(11):1766-74.
    View in: PubMed
    Score: 0,011
  42. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis. 2014 Jan 01; 209(1):56-65.
    View in: PubMed
    Score: 0,010
  43. Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009-2011. PLoS One. 2013; 8(2):e55682.
    View in: PubMed
    Score: 0,010
  44. Twenty-five years of outpatient influenza surveillance in South Africa, 1984-2008. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S153-8.
    View in: PubMed
    Score: 0,010
  45. Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S159-65.
    View in: PubMed
    Score: 0,010
  46. Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009. Clin Infect Dis. 2012 May; 54 Suppl 4:S334-8.
    View in: PubMed
    Score: 0,010
  47. Results of a safety and feasibility study of the diaphragm used with ACIDFORM Gel or K-Y Jelly. Contraception. 2010 Mar; 81(3):232-9.
    View in: PubMed
    Score: 0,008
  48. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population. Sex Transm Infect. 2010 Feb; 86(1):46-50.
    View in: PubMed
    Score: 0,008
  49. Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme. BJOG. 2009 Dec; 116(13):1805-8.
    View in: PubMed
    Score: 0,008
  50. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women. AIDS. 2009 Jul 31; 23(12):1531-8.
    View in: PubMed
    Score: 0,008
  51. Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months. Sex Transm Dis. 2007 Sep; 34(9):638-43.
    View in: PubMed
    Score: 0,007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.